LOS ANGELES (Reuters) - Genentech Inc said on Thursday it will ban on November 30 direct purchases of Avastin by independent compounding pharmacies, which repackage the cancer drug as a low-cost ...

Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...

WASHINGTON, Dec 20 (Reuters) - Genentech Inc has resolved a dispute with doctors over the use of its cancer drug Avastin, a much less costly alternative to the biotech company's Lucentis for macular ...

The Department of Veterans Affairs said it has stopped using the drug Avastin to treat eye disease, as it investigates concerns about serious infections and blindness from the drug, according to a ...